Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 07 January 2026

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1772783

Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer

This article is a correction to:

  1. Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer

    1. Read original article
Lu Zou,&#x;Lu Zou1,2†Jingjing Chen,&#x;Jingjing Chen1,2†Xinyuan Bai,Xinyuan Bai1,2Yingxin Wang,Yingxin Wang1,3Changchang LuChangchang Lu4Qiaoli WangQiaoli Wang1Subiyinuer Tuerhong,Subiyinuer Tuerhong1,3Mengzhu LiMengzhu Li2Qinghua ZhengQinghua Zheng3Fanyan Meng,,*Fanyan Meng1,3,5*Juan Du,*Juan Du1,2*
  • 1Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine, Nanjing, China
  • 2The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
  • 3Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China
  • 4Institute of Translational Medicine, Zhejiang University, Hangzhou, China
  • 5State Key Laboratory of Analytical Chemistry for Life Sciences, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China

A Correction on
Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer

By Zou L, Chen J, Bai X, Wang Y, Lu C, Wang Q, Tuerhong S, Li M, Zheng Q, Meng F and Du J (2025) Front. Immunol. 16:1693755. doi: 10.3389/fimmu.2025.1693755

An incorrect Funding statement was provided. The correct funder is “the National Natural Science Foundation of China (No. 82373280), Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (ZKX24021 and YKK24072), the provincial key medical disciplines during the “14th Five-Year Plan” period (ZDXK202233) and 2024 Annual Medical Research Projects of the Jiangsu Provincial Health Commission (K2024038)”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: KRAS G12V, bispecific T-cell engager (BiTE), IRGD, pancreatic cancer, T-cell infiltration

Citation: Zou L, Chen J, Bai X, Wang Y, Lu C, Wang Q, Tuerhong S, Li M, Zheng Q, Meng F and Du J (2026) Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer. Front. Immunol. 16:1772783. doi: 10.3389/fimmu.2025.1772783

Received: 23 December 2025; Accepted: 23 December 2025; Revised: 22 December 2025;
Published: 07 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Zou, Chen, Bai, Wang, Lu, Wang, Tuerhong, Li, Zheng, Meng and Du. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fanyan Meng, ZmFueWFubWVuZ0Bob3RtYWlsLmNvbQ==; Juan Du, ZHVqdWFuZ2x5eUAxNjMuY29t

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.